Circulating Tumour Cell-derived Xenograft As a Preclinical Platform For Metastatic Breast Cancer
Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer
KAHOUNOVA, Z.,
M. HRUSKOVA,
S. DRAPELA,
O. NAAR,
R. VICHOVA,
J. NAVRATIL,
P. FABIAN,
F. KOKAS,
A. HAMPL,
J. BOUCHAL,
K. SOUCEK
Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer.
British Journal of Cancer.
2026,
ISSN: 0007-0920,
PMID: 42151560,
PDF.